The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, 2025. The Zacks Consensus Estimate for fourth-quarter revenues is pegged at ...

Bayer Thai Co., Ltd. has been honoured with the 2025 Thailand Best Employer Brand Award, a prestigious recognition presented by the World HRD Congress and CHRO Asia. This accolade reaffirms Bayer Thai ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Bayer AG's stock demonstrated modest trading activity on Friday, settling at €21.80 with a marginal decline of 0.3%. Trading within a narrow corridor, the stock fluctuated between €21.76 and €21.94, ...

Donald Trump’s inaugural committee was funded by Amazon, Chevron, Coinbase, Coca-Cola, Comcast, ExxonMobil, GEO Group, ...

Union Finance Minister Nirmala Sitharaman presents the Union Budget 2025. Market reactions are swift, but historical data ...

Ballard Partners re-upped its agreement to lobby for the Democratic Republic of Congo amid escalating violence in the central ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Robert F. Kennedy Jr.’s chances of becoming HHS chief likely hinge on one of his more controversial stances: that vaccines ...

Explore sector-wise budget predictions for FY 25-26, highlighting allocations and challenges across various industries. Stay ...